Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 21.44
+0.37 (1.76%)
Mar 10, 2026, 12:55 PM CST
Porton Pharma Solutions Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,381 | 8,602 | 13,735 | 22,305 | 48,697 | 19,821 | Upgrade
|
| Market Cap Growth | 20.96% | -37.37% | -38.42% | -54.20% | 145.68% | 155.21% | Upgrade
|
| Enterprise Value | 11,934 | 9,403 | 13,249 | 20,598 | 48,168 | 18,944 | Upgrade
|
| Last Close Price | 21.07 | 15.77 | 24.34 | 38.24 | 83.52 | 34.02 | Upgrade
|
| PE Ratio | - | - | 51.47 | 11.12 | 92.95 | 61.10 | Upgrade
|
| Forward PE | 91.61 | 54.14 | 27.07 | 12.63 | 71.85 | 51.44 | Upgrade
|
| PS Ratio | 3.32 | 2.86 | 3.75 | 3.17 | 15.68 | 9.57 | Upgrade
|
| PB Ratio | 2.07 | 1.59 | 2.25 | 3.45 | 11.63 | 5.84 | Upgrade
|
| P/TBV Ratio | 2.37 | 1.85 | 2.62 | 4.13 | 13.64 | 6.48 | Upgrade
|
| P/FCF Ratio | 65.99 | - | - | 16.03 | - | 179.53 | Upgrade
|
| P/OCF Ratio | 21.18 | 21.21 | 21.83 | 8.70 | 101.42 | 39.30 | Upgrade
|
| PEG Ratio | - | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | Upgrade
|
| EV/Sales Ratio | 3.48 | 3.12 | 3.61 | 2.93 | 15.51 | 9.14 | Upgrade
|
| EV/EBITDA Ratio | 23.05 | 98.05 | 22.82 | 8.40 | 66.91 | 38.06 | Upgrade
|
| EV/EBIT Ratio | 120.63 | - | 45.39 | 9.29 | 86.65 | 51.66 | Upgrade
|
| EV/FCF Ratio | 69.20 | - | - | 14.81 | - | 171.59 | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.36 | 0.32 | 0.14 | 0.18 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 3.33 | 11.40 | 3.08 | 0.37 | 0.99 | 0.50 | Upgrade
|
| Debt / FCF Ratio | 9.99 | - | - | 0.66 | - | 2.28 | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | 0.09 | 0.00 | -0.30 | -0.11 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.89 | 5.02 | 0.01 | -0.79 | -0.66 | -2.04 | Upgrade
|
| Net Debt / FCF Ratio | 2.29 | -5.66 | -0.01 | -1.38 | 1.60 | -9.19 | Upgrade
|
| Asset Turnover | 0.39 | 0.33 | 0.38 | 0.84 | 0.56 | 0.49 | Upgrade
|
| Inventory Turnover | 3.31 | 3.10 | 2.76 | 4.10 | 3.11 | 3.20 | Upgrade
|
| Quick Ratio | 1.38 | 1.37 | 1.94 | 1.47 | 1.12 | 1.72 | Upgrade
|
| Current Ratio | 1.87 | 1.90 | 2.63 | 1.81 | 1.52 | 2.22 | Upgrade
|
| Return on Equity (ROE) | -1.35% | -6.36% | 2.79% | 36.34% | 12.55% | 10.01% | Upgrade
|
| Return on Assets (ROA) | 0.71% | -1.54% | 1.87% | 16.59% | 6.28% | 5.42% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.68% | -3.73% | 3.90% | 46.32% | 15.82% | 14.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.40% | -3.20% | 3.70% | 31.10% | 12.50% | 10.40% | Upgrade
|
| Earnings Yield | -0.01% | -3.35% | 1.94% | 8.99% | 1.08% | 1.64% | Upgrade
|
| FCF Yield | 1.52% | -0.99% | -3.65% | 6.24% | -0.61% | 0.56% | Upgrade
|
| Dividend Yield | - | - | 2.00% | 2.89% | 0.23% | 0.36% | Upgrade
|
| Payout Ratio | - | - | 234.79% | 6.44% | 15.80% | 25.44% | Upgrade
|
| Buyback Yield / Dilution | 1.59% | 0.31% | -0.21% | -0.62% | 0.11% | -1.99% | Upgrade
|
| Total Shareholder Return | 1.59% | 0.31% | 1.79% | 2.27% | 0.34% | -1.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.